BRUSSELS, Oct 22 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR: Quote, Profile, Research) said on Monday it had been granted co-promotion rights in the United States for Abbott's (ABT.N: Quote, Profile, Research) lipid therapy SIMCOR.
